Biote Corp. BTMD Ratios & Valuation
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | 70.1%-1.2pp | 71.5%+0.9pp | 72.4%+2.5pp | 72%+2.4pp | 71.3%+1.9pp | |
| Operating margin | 15.4%-0.1pp | 18.5%+2.5pp | 16.1%-1.7pp | 17.8%— | 15.5%— | |
| Net margin | 8.3%-2.3pp | 14.1%+12.5pp | 14.7%+11.0pp | 15.7%+13.6pp | 10.6%+7.4pp | |
| Efficiency | ||||||
| Asset turnover | 1.8×+0.4× | 1.7×+0.3× | 1.8×+0.3× | 2×+0.4× | 1.4×+0.1× | |
| Liquidity | ||||||
| Current ratio | 1.3×-0.1× | 1.2×-0.1× | 1×-0.5× | 1×-0.4× | 1.4×-3.3× | |
| Leverage | ||||||
| Net debt / EBITDA | 3×+1.0× | 2.1×0.0× | 2.2×+0.3× | 2.3×-0.3× | 2×+0.9× | |
| Per Share | ||||||
| Book value per share | -$1.56+36.0% | -$1.60+48.3% | -$1.98+50.9% | -$2.68+38.1% | -$2.44-134% | |
| Valuation | ||||||
| Market capitalization | $57.33M-51.2% | $79.77M-58.5% | $95.08M-45.0% | $125.63M-44.5% | $104.85M-49.4% | |
| Price / earnings | 3.7×-0.1× | 2.9×-58.0× | 3.3×-20.8× | 4×— | 5×— | |
| Price / sales | 0.3×-0.3× | 0.4×-0.6× | 0.5×-0.4× | 0.6×-0.6× | 0.5×-0.6× | |
| EV / EBITDA | 5×-0.7× | 4.1×-3.4× | 4.9×-1.5× | 5.5×-3.9× | 5×-2.0× | |
| Dividend yield | 2.2%+0.6pp | 2.2%-0.3pp | 1.8%-1.6pp | 1.7%-1.1pp | 5.1%+2.4pp |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Biote Corp.'s profit margins?
- Biote Corp. (BTMD) runs a 70.1% gross margin and a 15.4% operating margin, with a 8.3% net margin.
- Where do Biote Corp.'s ratios come from?
- Every ratio is computed from Biote Corp.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
